[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.124.106. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 1989

Nonsteroidal Anti-inflammatory Drugs

Author Affiliations

Boston, Mass

 

edited by N. J. Lowe and C. N. Hensby, 158 pp, with black-and-white and color illus, $99.50, New York, NY: S Karger AG; 1989.

Arch Dermatol. 1989;125(10):1449. doi:10.1001/archderm.1989.01670220147036

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

Nonsteroidal Anti-inflammatory Drugs is volume 2 of the Karger series Pharmacology and the Skin. This book represents a progress report on the pharmacology of nonsteroidal anti-inflammatory drugs in the context of the skin, with particular emphasis on the development of topical formulations of nonsteroidal anti-inflammatory drugs. This book consists of eight chapters written by 12 authors. The topics covered include the role of reactive oxygen species in inflammation, formulation of anti-inflammatory agents, in vitro models for the evaluation of anti-inflammatory drug action, effects of anti-inflammatory drugs on cutaneous inflammation and blood vessels, in vitro animal models for studying drug action, topical nonsteroidal antiinflammatory drugs, and adverse cutaneous reactions to nonsteroidal anti-inflammatory drugs.

A recurring theme in this book is that there is no convincing evidence that topical or systemic nonsteroidal anti-inflammatory drugs are of therapeutic benefit in the treatment of skin diseases in man. This theme immediately raises the question

First Page Preview View Large
First page PDF preview
First page PDF preview
×